Paper Details
- Home
- Paper Details
Effects of CYP2C19, CYP2C9 and CYP3A4 gene polymorphisms on plasma voriconazole levels in Chinese pediatric patients.
Author: FanXinghua, WenZhipeng, YangJihong, YangYi, ZhangHong, ZhengXiaoli
Original Abstract of the Article :
Voriconazole is the most commonly used antifungal agent in clinical application. Previous studies suggested that voriconazole was extensively metabolized by CYP450 enzyme system, including CYP2C19, CYP2C9 and CYP3A4, which contributed to the individual variability of the pharmacokinetic process of v...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/35081606
データ提供:米国国立医学図書館(NLM)
Investigating the Impact of CYP450 Polymorphisms on Voriconazole Levels in Chinese Pediatric Patients
Voriconazole, a widely used antifungal agent, is extensively metabolized by the CYP450 enzyme system. This study delves into the impact of CYP2C19, CYP2C9, and CYP3A4 gene polymorphisms on plasma voriconazole concentrations in Chinese pediatric patients. By understanding the variability in drug metabolism, clinicians can personalize drug therapy, optimizing therapeutic outcomes and minimizing potential adverse effects.
Tailoring Treatment for Individual Needs
The study highlights the importance of considering genetic variations in drug metabolism. By identifying individuals with specific CYP450 polymorphisms, clinicians can tailor voriconazole dosing, ensuring optimal drug efficacy and minimizing the risk of adverse effects. This approach is crucial for personalized medicine, allowing for more effective and safer treatment outcomes.
Navigating the Complexities of Drug Metabolism
This study adds to our understanding of the complex interplay between genetic variations and drug metabolism. It reminds us that individuals respond differently to medications, and understanding these differences is crucial for effective and safe treatment. This research contributes to the growing field of pharmacogenomics, paving the way for personalized drug therapy and improved patient care.
Dr.Camel's Conclusion
This study underscores the critical role of genetic variations in drug metabolism. By understanding the impact of CYP450 polymorphisms on voriconazole levels, clinicians can personalize treatment strategies, optimizing efficacy and minimizing adverse effects. This research contributes to the growing field of pharmacogenomics, paving the way for more effective and safer drug therapies.
Date :
- Date Completed 2022-05-09
- Date Revised 2023-09-11
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.